Further investigation of this hypothesis is warranted, findings from which could lead to define novel molecular mechanism that regulates FASN expression during castration-resistant progression of PCa, thereby providing alternative strategies for effective treatment of castration-resistant PCa in the clinic. The gene discussed is FASN; the disease is posterior cortical atrophy.